Share
Wellness

Anti-Inflammatory Positioning Becomes the Next Big CPG Claim

Brands are pivoting from 'high protein' to 'anti-inflammatory,' featuring turmeric, ginger, omega-3, and tart cherry as hero ingredients.

By FTW Editorial·May 20, 2026·5 min read
Anti-Inflammatory Positioning Becomes the Next Big CPG Claim

Brands are pivoting from 'high protein' to 'anti-inflammatory,' featuring turmeric, ginger, omega-3, and tart cherry as hero ingredients.

What happened

RXBar, KIND, Lärabar, and challenger brands are reformulating snack lines around inflammation-reduction claims backed by clinical citations.

Why it matters

It is the natural successor to gut-health positioning: scientifically grounded, broadly relevant, and not yet category-saturated.

Market impact

Expect FTC and FDA scrutiny on claims to intensify, separating credible brands from supplement-style overreach.

Consumer insight

Consumers in their 30s and 40s associate inflammation with aging, joint pain, and cognitive decline — a high-conviction wellness driver.

Strategic takeaway

R&D and brand teams should pre-vet ingredient claims with clinical data now. The credibility bar will rise fast.

Get the next signal in your inbox.

Daily food industry intelligence — free.

More signals